Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Mar;58(3):222–226. doi: 10.1136/thorax.58.3.222

Association of CCR5Δ32 with reduced risk of childhood but not adult asthma

P Srivastava 1, P Helms 1, D Stewart 1, M Main 1, G Russell 1
PMCID: PMC1746589  PMID: 12612298

Abstract

Background: A number of potential candidate genes have been implicated in the pathogenesis of asthma. A 32 base pair deletion in the CCR5 gene renders this chemokine receptor non-functioning and has been shown to be associated with a reduced prevalence of asthma in childhood. The mechanism may be related to impairment of pathogen entry into cells and modified host inflammatory response. We sought to determine the influence of the CCR5Δ32 mutation on asthma and allergy in the transition from childhood to adulthood.

Methods: 627 individuals first studied as part of a whole population schoolchildren cohort in 1989 when aged 8–12 years were followed up 10 years later for respiratory and allergy symptoms and laboratory markers of atopy. CCR5Δ32 status was also characterised and the association with childhood and adulthood symptoms determined.

Results: The follow up sample was representative of the original cohort except for a slightly greater prevalence of symptomatic individuals. As children, none who were homozygous for the CCR5Δ32 mutation had a current physician's diagnosis of asthma. In multivariate analysis and controlling for known confounders, the protective effect of carrying the allele in childhood was highly significant (OR 0.31, 95% CI 0.14 to 0.72, p=0.006). There was no protective association with "current asthma" as classified in adulthood within the same population. Subjective or laboratory markers of atopy in childhood or adulthood were not associated with the CCR5Δ32 mutation. Methacholine bronchial hyperresponsiveness in adulthood was also unrelated to gene carrier status.

Conclusions: In a population with a high allelic frequency for the CCR5Δ32 mutation, a significant protection against childhood asthma is evident which is independent of atopy. This protection is lost in the transition between childhood and early adulthood. The contribution of different genetic candidates to the expression of asthma may change with advancing maturity and confound the interpretation of association and linkage studies unless age is taken into account.

Full Text

The Full Text of this article is available as a PDF (145.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asher M. I., Keil U., Anderson H. R., Beasley R., Crane J., Martinez F., Mitchell E. A., Pearce N., Sibbald B., Stewart A. W. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995 Mar;8(3):483–491. doi: 10.1183/09031936.95.08030483. [DOI] [PubMed] [Google Scholar]
  2. Burney P. G., Luczynska C., Chinn S., Jarvis D. The European Community Respiratory Health Survey. Eur Respir J. 1994 May;7(5):954–960. doi: 10.1183/09031936.94.07050954. [DOI] [PubMed] [Google Scholar]
  3. Burr M. L., Butland B. K., King S., Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child. 1989 Oct;64(10):1452–1456. doi: 10.1136/adc.64.10.1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  5. Conti P., DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 2001 May-Jun;22(3):133–137. doi: 10.2500/108854101778148737. [DOI] [PubMed] [Google Scholar]
  6. Dawson B., Illsley R., Horobin G., Mitchell R. A survey of childhood asthma in Aberdeen. Lancet. 1969 Apr 19;1(7599):827–830. doi: 10.1016/s0140-6736(69)92082-0. [DOI] [PubMed] [Google Scholar]
  7. Dawson T. C., Beck M. A., Kuziel W. A., Henderson F., Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol. 2000 Jun;156(6):1951–1959. doi: 10.1016/S0002-9440(10)65068-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ferris B. G. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1–120. [PubMed] [Google Scholar]
  9. Godden D. J., Ross S., Abdalla M., McMurray D., Douglas A., Oldman D., Friend J. A., Legge J. S., Douglas J. G. Outcome of wheeze in childhood. Symptoms and pulmonary function 25 years later. Am J Respir Crit Care Med. 1994 Jan;149(1):106–112. doi: 10.1164/ajrccm.149.1.8111567. [DOI] [PubMed] [Google Scholar]
  10. Hall I. P., Wheatley A., Christie G., McDougall C., Hubbard R., Helms P. J. Association of CCR5 delta32 with reduced risk of asthma. Lancet. 1999 Oct 9;354(9186):1264–1265. doi: 10.1016/s0140-6736(99)03425-x. [DOI] [PubMed] [Google Scholar]
  11. Ianni A., Majore S., Arzani D., Carboni I., Corbo G. M., Romano-Spica V. CCR2 and CCR5 gene polymorphisms in children with recurrent respiratory infections. Respir Med. 2001 May;95(5):430–432. doi: 10.1053/rmed.2001.1063. [DOI] [PubMed] [Google Scholar]
  12. Iyer R. K., Kim P. S., Bando J. M., Lu K. V., Gregg J. P., Grody W. W. A multiethnic study of Delta32ccr5 and ccr2b-V64I allele distribution in four Los Angeles populations. Diagn Mol Pathol. 2001 Jun;10(2):105–110. doi: 10.1097/00019606-200106000-00006. [DOI] [PubMed] [Google Scholar]
  13. Loetscher P., Uguccioni M., Bordoli L., Baggiolini M., Moser B., Chizzolini C., Dayer J. M. CCR5 is characteristic of Th1 lymphocytes. Nature. 1998 Jan 22;391(6665):344–345. doi: 10.1038/34814. [DOI] [PubMed] [Google Scholar]
  14. Lucotte G., Mercier G. Distribution of the CCR5 gene 32-bp deletion in Europe. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):174–177. doi: 10.1097/00042560-199810010-00011. [DOI] [PubMed] [Google Scholar]
  15. Mangano A., Gonzalez E., Dhanda R., Catano G., Bamshad M., Bock A., Duggirala R., Williams K., Mummidi S., Clark R. A. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis. 2001 May 2;183(11):1574–1585. doi: 10.1086/320705. [DOI] [PubMed] [Google Scholar]
  16. Mitchell T. J., Walley A. J., Pease J. E., Venables P. J., Wiltshire S., Williams T. J., Cookson W. O. Delta 32 deletion of CCR5 gene and association with asthma or atopy. Lancet. 2000 Oct 28;356(9240):1491–1492. doi: 10.1016/S0140-6736(00)03144-5. [DOI] [PubMed] [Google Scholar]
  17. Ninan T. K., Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ. 1992 Apr 4;304(6831):873–875. doi: 10.1136/bmj.304.6831.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Oswald H., Phelan P. D., Lanigan A., Hibbert M., Bowes G., Olinsky A. Outcome of childhood asthma in mid-adult life. BMJ. 1994 Jul 9;309(6947):95–96. doi: 10.1136/bmj.309.6947.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Robertson C. F., Heycock E., Bishop J., Nolan T., Olinsky A., Phelan P. D. Prevalence of asthma in Melbourne schoolchildren: changes over 26 years. BMJ. 1991 May 11;302(6785):1116–1118. doi: 10.1136/bmj.302.6785.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Roorda R. J. Prognostic factors for the outcome of childhood asthma in adolescence. Thorax. 1996 Jan;51 (Suppl 1):S7–12. doi: 10.1136/thx.51.suppl_1.s7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C. M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996 Aug 22;382(6593):722–725. doi: 10.1038/382722a0. [DOI] [PubMed] [Google Scholar]
  22. Simpson C. R., Anderson W. J. A., Helms P. J., Taylor M. W., Watson L., Prescott G. J., Godden D. J., Barker R. N. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy. 2002 Jan;32(1):37–42. doi: 10.1046/j.0022-0477.2001.01250.x. [DOI] [PubMed] [Google Scholar]
  23. Stephens J. C., Reich D. E., Goldstein D. B., Shin H. D., Smith M. W., Carrington M., Winkler C., Huttley G. A., Allikmets R., Schriml L. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet. 1998 Jun;62(6):1507–1515. doi: 10.1086/301867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stevenson E. C., Turner G., Heaney L. G., Schock B. C., Taylor R., Gallagher T., Ennis M., Shields M. D. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy. 1997 Sep;27(9):1027–1035. doi: 10.1111/j.1365-2222.1997.tb01254.x. [DOI] [PubMed] [Google Scholar]
  25. Strachan D. P. Hay fever, hygiene, and household size. BMJ. 1989 Nov 18;299(6710):1259–1260. doi: 10.1136/bmj.299.6710.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Szalai C., Bojszkó A., Bekö G., Falus A. Prevalence of CCR5delta32 in allergic diseases. Lancet. 2000 Jan 1;355(9197):66–66. doi: 10.1016/S0140-6736(05)72005-5. [DOI] [PubMed] [Google Scholar]
  27. Tonnel A. B., Gosset P., Tillie-Leblond I. Characteristics of the Inflammatory response in bronchial lavage fluids from patients with status asthmaticus. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):267–271. doi: 10.1159/000053729. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES